• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期阿片类药物使用障碍:利用医护人员的认知为综合治疗提供依据。

Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment.

作者信息

Titus-Glover Doris, Shaya Fadia T, Welsh Christopher, Qato Danya M, Shah Savyasachi, Gresssler Laura E, Vivrette Rebecca

机构信息

Department of Pharmaceutical Health Services Research (PHSR), School of Pharmacy, University of Maryland, Baltimore, USA.

Present address: School of Nursing, University of Maryland, Baltimore, Universities at Shady Grove, 9640 Gudelsky Drive, Rockville, MD, 20850, USA.

出版信息

BMC Health Serv Res. 2021 Mar 10;21(1):215. doi: 10.1186/s12913-021-06182-0.

DOI:10.1186/s12913-021-06182-0
PMID:33691677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7945667/
Abstract

BACKGROUND

Medications for opioid use disorder (MOUD) are recommended with adjuvant behavioral therapies, counseling, and other services for comprehensive treatment of maternal opioid use disorder. Inadequate access to treatment, lack of prescribing providers and complex delivery models are among known barriers to care. Multi-disciplinary provider input can be leveraged to comprehend factors that facilitate or inhibit treatment. The objective of this study is to explore provider perceptions of MOUD and factors critical to comprehensive treatment delivery to improve the care of pregnant women with opioid use disorder.

METHODS

A qualitative research approach was used to gather data from individual provider and group semi-structured interviews. Providers (n = 12) responded to questions in several domains related to perceptions of MOUD, treatment delivery, access to resources, and challenges/barriers. Data were collected, transcribed, coded (by consensus) and emerging themes were analyzed using grounded theory methodology.

RESULTS

Emerging themes revealed persistent gaps in treatment and challenges in provider, health systems and patient factors. Providers perceived MOUD to be a "lifeline" to women.

CONCLUSIONS

Inconsistencies in treatment provision, access and uptake can be improved by leveraging provider perceptions, direct experiences and recommendations for an integrated team-based, patient-centered approach to guide the care of pregnant women with opioid use disorder.

摘要

背景

阿片类物质使用障碍药物(MOUD)与辅助行为疗法、咨询及其他服务一同被推荐用于全面治疗孕产妇阿片类物质使用障碍。治疗途径不足、开处方的医疗服务提供者缺乏以及复杂的服务提供模式是已知的医疗障碍。多学科医疗服务提供者的意见可用于理解促进或阻碍治疗的因素。本研究的目的是探讨医疗服务提供者对MOUD的看法以及全面治疗服务中至关重要的因素,以改善对患有阿片类物质使用障碍的孕妇的护理。

方法

采用定性研究方法,通过个体医疗服务提供者访谈和小组半结构化访谈收集数据。医疗服务提供者(n = 12)回答了与对MOUD的看法、治疗服务提供、资源获取以及挑战/障碍等几个领域相关的问题。收集数据、转录、编码(通过共识),并使用扎根理论方法分析新出现的主题。

结果

新出现的主题揭示了治疗方面持续存在的差距以及医疗服务提供者、卫生系统和患者因素方面的挑战。医疗服务提供者认为MOUD是女性的“生命线”。

结论

通过利用医疗服务提供者的看法、直接经验和建议,采用基于团队的、以患者为中心的综合方法来指导对患有阿片类物质使用障碍的孕妇的护理,可以改善治疗提供、获取和接受方面的不一致情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d1/7945667/2d594fbc3672/12913_2021_6182_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d1/7945667/2d594fbc3672/12913_2021_6182_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d1/7945667/2d594fbc3672/12913_2021_6182_Fig1_HTML.jpg

相似文献

1
Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment.孕期阿片类药物使用障碍:利用医护人员的认知为综合治疗提供依据。
BMC Health Serv Res. 2021 Mar 10;21(1):215. doi: 10.1186/s12913-021-06182-0.
2
The Lived Experiences of Pregnant and Parenting Women in Recovery Toward Medication Treatment for Opioid Use Disorder.患有阿片类药物使用障碍的孕妇和哺乳期妇女在接受药物治疗过程中的生活体验。
Subst Use Addctn J. 2024 Jul;45(3):367-377. doi: 10.1177/29767342231221055. Epub 2024 Jan 22.
3
Expert providers implement integrated and coordinated care in opioid use disorder treatment.专家提供者在阿片类药物使用障碍治疗中实施综合协调护理。
Int J Drug Policy. 2024 Oct;132:104567. doi: 10.1016/j.drugpo.2024.104567. Epub 2024 Sep 5.
4
"You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.“你必须服用这种药物,但服用它却会受到惩罚”:围产期治疗阿片类药物使用障碍时缺乏自主性、选择权以及对药物的恐惧。
J Subst Abuse Treat. 2022 Aug;139:108765. doi: 10.1016/j.jsat.2022.108765. Epub 2022 Mar 18.
5
Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates.提供者对阿片类药物使用障碍(MOUD)药物的看法:在阿片类药物过量死亡率高的社区进行的定性研究。
Subst Abus. 2022;43(1):742-748. doi: 10.1080/08897077.2021.2007518.
6
Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study).患有阿片类药物使用障碍的孕妇的产科疼痛管理:患者和提供者观点的定性和定量比较(QUEST 研究)。
Addiction. 2023 Jun;118(6):1093-1104. doi: 10.1111/add.16134. Epub 2023 Feb 13.
7
Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder.规定与惩罚:强制报告对阿片类物质使用障碍产前药物使用的不利影响
Matern Child Health J. 2023 Dec;27(Suppl 1):104-112. doi: 10.1007/s10995-023-03672-x. Epub 2023 May 31.
8
Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.为患有阿片类药物使用障碍的孕妇提供治疗的途径:社区阿片类药物治疗提供者的观点。
J Subst Abuse Treat. 2021 Jul;126:108338. doi: 10.1016/j.jsat.2021.108338. Epub 2021 Feb 25.
9
Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them.妊娠和育儿相关因素对接受阿片类药物使用障碍药物治疗的阻碍:一项对治疗中的女性、终止治疗的女性以及为其提供服务的专业人员进行的多层面定性研究。
Womens Health (Lond). 2024 Jan-Dec;20:17455057231224181. doi: 10.1177/17455057231224181.
10
Implementation of medication for opioid use disorder treatment during a natural disaster: The PROUD-LA study.自然灾害期间阿片类药物使用障碍治疗药物的实施:PROUD-LA 研究。
J Subst Use Addict Treat. 2024 Oct;165:209469. doi: 10.1016/j.josat.2024.209469. Epub 2024 Jul 31.

引用本文的文献

1
Systemic barriers and stigma: Healthcare provider perspectives on perinatal and neonatal care in the fentanyl crisis.系统性障碍与污名化:医疗服务提供者对芬太尼危机中围产期和新生儿护理的看法。
J Subst Use Addict Treat. 2025 May;172:209644. doi: 10.1016/j.josat.2025.209644. Epub 2025 Feb 20.
2
Just an unfair score: Perceptions of gender inequity in the treatment of substance use disorders among women involved in the criminal legal system.只是一个不公平的评分:参与刑事法律系统的女性在物质使用障碍治疗中对性别不平等的认知。
J Subst Use Addict Treat. 2025 Feb;169:209587. doi: 10.1016/j.josat.2024.209587. Epub 2024 Nov 29.
3

本文引用的文献

1
Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder.ASAM 国家药物使用障碍治疗实践指南重点更新执行摘要。
J Addict Med. 2020 Mar/Apr;14(2):99-112. doi: 10.1097/ADM.0000000000000635.
2
Maternal Mortality in the United States: Updates on Trends, Causes, and Solutions.美国的孕产妇死亡率:趋势、原因及解决方案的最新情况
Neoreviews. 2019 Oct;20(10):e561-e574. doi: 10.1542/neo.20-10-e561.
3
State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
Co-Locating Obstetrics and Addiction Medicine Clinics to Improve Attendance in Services for Pregnant People with Opioid Use Disorder.
将产科和成瘾医学诊所设在同一地点,以提高为患有阿片类药物使用障碍的孕妇提供服务的就诊率。
Psychiatr Res Clin Pract. 2023 Dec 9;6(2):36-41. doi: 10.1176/appi.prcp.20230033. eCollection 2024 Summer.
4
Strategies to improve delivery of equitable and evidence-informed care for pregnant and birthing people with a substance use disorder in acute care settings: A scoping review protocol.改善急性护理环境中患有物质使用障碍的孕妇和产妇获得公平和基于证据的护理的策略:范围综述方案。
PLoS One. 2024 Mar 18;19(3):e0300183. doi: 10.1371/journal.pone.0300183. eCollection 2024.
5
Reducing Fear to Help Build Healthy Families: Investing in Non-Punitive Approaches to Helping People with Substance Use Disorder.减少恐惧,帮助建立健康家庭:投资于非惩罚性方法,帮助有药物使用障碍的人。
Matern Child Health J. 2023 Dec;27(Suppl 1):177-181. doi: 10.1007/s10995-023-03772-8. Epub 2023 Sep 27.
6
Self-Identified Stage in Recovery and Substance-Use Behaviors among Pregnant and Postpartum Women and People with Opioid Use Disorder.怀孕及产后女性和患有阿片类物质使用障碍者在康复过程中的自我认定阶段及物质使用行为
Healthcare (Basel). 2023 Aug 25;11(17):2392. doi: 10.3390/healthcare11172392.
7
Attitudes Toward Medication for Opioid Use Disorder Among Pregnant and Postpartum Women and People Seeking Treatment.孕妇和产后妇女及寻求治疗者对阿片类药物使用障碍药物治疗的态度。
J Addict Med. 2023;17(3):356-359. doi: 10.1097/ADM.0000000000001113. Epub 2022 Dec 13.
8
A scoping review of opioid harm reduction interventions for equity-deserving populations.针对应受公平对待人群的阿片类药物危害减少干预措施的范围综述。
Lancet Reg Health Am. 2022 May 11;12:100271. doi: 10.1016/j.lana.2022.100271. eCollection 2022 Aug.
9
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder.阿内特因德凯德:孕期和产后阿片类药物使用障碍患者的综合护理模式
J Addict Med. 2023;17(2):131-139. doi: 10.1097/ADM.0000000000001052. Epub 2022 Aug 17.
10
Patients' Perspectives on Coming Off Opioid Agonist Treatment: A Qualitative Study.患者对停用阿片类激动剂治疗的看法:一项定性研究。
Subst Abuse. 2022 Jun 21;16:11782218221107021. doi: 10.1177/11782218221107021. eCollection 2022.
解决孕妇和产后妇女阿片类药物使用障碍以及受物质(包括患有新生儿戒断综合征的婴儿)产前暴露问题的国家策略。
MMWR Morb Mortal Wkly Rep. 2019 Sep 13;68(36):777-783. doi: 10.15585/mmwr.mm6836a1.
4
Selecting a Grounded Theory Approach for Nursing Research.为护理研究选择扎根理论方法。
Glob Qual Nurs Res. 2018 Oct 4;5:2333393618799571. doi: 10.1177/2333393618799571. eCollection 2018 Jan-Dec.
5
Prison: Pipeline to Women's Preventative Health.监狱:通往女性预防性健康的渠道。
R I Med J (2013). 2018 Oct 1;101(8):23-26.
6
Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.分娩住院时记录的阿片类药物使用障碍 - 美国,1999-2014 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr.mm6731a1.
7
Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.美国接受公共资金资助的阿片类药物使用障碍治疗项目的孕妇接受药物治疗的趋势和差异。
J Subst Abuse Treat. 2018 Jun;89:67-74. doi: 10.1016/j.jsat.2018.04.003. Epub 2018 Apr 6.
8
Management of opioid use disorders: a national clinical practice guideline.阿片类物质使用障碍的管理:一项国家临床实践指南。
CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958.
9
Patterns of Opioid Prescription and Use After Cesarean Delivery.剖宫产术后阿片类药物的处方和使用模式
Obstet Gynecol. 2017 Jul;130(1):29-35. doi: 10.1097/AOG.0000000000002093.
10
Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.孕期阿片类药物使用、新生儿戒断综合征及儿童期结局:尤妮斯·肯尼迪·施莱佛国家儿童健康与人类发展研究所、美国妇产科医师学会、美国儿科学会、母胎医学协会、疾病控制与预防中心以及美国疾病防控中心和“美邦”基金会联合研讨会执行摘要
Obstet Gynecol. 2017 Jul;130(1):10-28. doi: 10.1097/AOG.0000000000002054.